Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Sinopharm has agreed to purchase and distribute at least $3.85 million of the company’s SRS II Systems.
SRS II Systems are designed to be used as a minimally invasive treatment for Gastroesophageal Reflux Disease.
More Articles on Gastroenterology:
Dr. Nanda Kerkar Joins Children’s Hospital LA
Study Shows Accuracy of Optical Biopsy Over Traditional Endoscopy
First Alabama Pediatric Colorectal Clinic Opens
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
